Rankings
▼
Calendar
RCUS (Arcus Biosciences, Inc.) Stock Financials & Earnings | Market Cap Arena
RCUS
Arcus Biosciences, Inc.
Mkt Cap
$2B
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NYSE
Revenue (TTM)
$247M
Net Income (TTM)
-$353M
EPS (TTM)
-$3.29
Free Cash Flow (TTM)
-$484M
Gross Margin
98.0%
Op. Margin
-156.3%
Net Margin
-142.9%
FCF Margin
-196.0%
P/S Ratio (TTM)
9.9x
P/E Ratio (TTM)
—
YoY Rev Growth
-4.3%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$25M
$25M
-$86M
Q2 23
$29M
$29M
-$83M
Q3 23
$32M
$32M
-$80M
Q4 23
$31M
$31M
-$91M
Q1 24
$145M
$145M
-$16M
Q2 24
$39M
$39M
-$106M
Q3 24
$48M
$48M
-$105M
Q4 24
$26M
$26M
-$103M
Q1 25
$28M
$28M
-$122M
Q2 25
$160M
$160M
-$8M
Q3 25
$26M
$24M
-$142M
Q4 25
$33M
$30M
-$114M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
20.7x
—
Q2 23
20.3x
—
Q3 23
20.5x
—
Q4 23
21.0x
—
Q1 24
10.3x
—
Q2 24
9.9x
—
Q3 24
9.3x
—
Q4 24
9.5x
—
Q1 25
17.4x
—
Q2 25
9.4x
—
Q3 25
10.2x
—
Q4 25
9.9x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$98M
-$101M
Q2 23
-$57M
-$62M
Q3 23
-$63M
-$73M
Q4 23
-$88M
-$94M
Q1 24
-$2M
-$6M
Q2 24
-$94M
-$94M
Q3 24
$26M
$25M
Q4 24
-$100M
-$101M
Q1 25
-$132M
-$133M
Q2 25
-$133M
-$133M
Q3 25
-$97M
-$97M
Q4 25
-$120M
-$121M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$3M
Q2 23
$5M
Q3 23
$10M
Q4 23
$6M
Q1 24
$4M
Q2 24
$0
Q3 24
$1M
Q4 24
$1M
Q1 25
$1M
Q2 25
$0
Q3 25
$0
Q4 25
$1M
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+38.9%
+30.6%
Q2 23
+7.4%
+16.7%
Q3 23
-3.0%
+8.7%
Q4 23
-7.9%
+12.9%
Q1 24
+480.0%
+45.0%
Q2 24
+34.5%
+29.5%
Q3 24
+50.0%
+36.6%
Q4 24
-16.1%
+5.7%
Q1 25
-80.7%
-6.8%
Q2 25
+310.3%
+15.9%
Q3 25
-45.8%
+9.8%
Q4 25
+26.9%
+14.0%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$0
0.0%
Q2 23
$18M
62.1%
Q3 23
$18M
56.3%
Q4 23
$0
0.0%
Q1 24
$20M
13.8%
Q2 24
$20M
51.3%
Q3 24
$19M
39.6%
Q4 24
$17M
65.4%
Q1 25
$16M
57.1%
Q2 25
$15M
9.4%
Q3 25
$14M
53.8%
Q4 25
$15M
45.5%
marketcaparena.com
OpEx Breakdown
R&D
G&A
Quarter
R&D
G&A
Q1 23
$81M
$30M
Q2 23
$84M
$28M
Q3 23
$82M
$30M
Q4 23
$93M
$29M
Q1 24
$109M
$32M
Q2 24
$115M
$30M
Q3 24
$123M
$30M
Q4 24
$101M
$28M
Q1 25
$122M
$28M
Q2 25
$139M
$29M
Q3 25
$141M
$27M
Q4 25
$121M
$26M
marketcaparena.com
Revenue Segments
License and Development Services Revenue
Other Collaboration Revenue
Quarter
License and Development Services Revenue
Other Collaboration Revenue
Q1 23
$17M
$8M
Q2 23
$19M
$10M
Q3 23
$22M
$10M
Q1 24
$135M
$10M
Q2 24
$28M
$11M
Q3 24
$41M
$7M
Q1 25
$20M
$8M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$238M
$716M
$954M
Q2 23
$230M
$700M
$930M
Q3 23
$184M
$615M
$799M
Q4 23
$127M
$632M
$759M
Q1 24
$185M
$810M
$995M
Q2 24
$156M
$813M
$969M
Q3 24
$201M
$888M
$1.1B
Q4 24
$150M
$828M
$978M
Q1 25
$192M
$805M
$997M
Q2 25
$248M
$663M
$911M
Q3 25
$238M
$593M
$831M
Q4 25
$222M
$759M
$981M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
73M
+0.6%
Q2 23
73M
+0.3%
Q3 23
75M
+1.9%
Q4 23
75M
+0.5%
Q1 24
86M
+14.9%
Q2 24
91M
+5.7%
Q3 24
91M
+0.3%
Q4 24
92M
+0.3%
Q1 25
98M
+7.3%
Q2 25
107M
+8.2%
Q3 25
107M
+0.0%
Q4 25
107M
+0.8%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 16
—
—
FY 17
—
—
FY 18
$77K
108
FY 19
$108K
139
FY 20
$331K
236
FY 21
$1M
366
FY 22
$224K
500
FY 23
$203K
577
FY 24
$411K
627
FY 25
$1K
200K
marketcaparena.com